The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Zeynep Arzu Yeğin Ferda Can Sanem Gökçen Rezzan Eren Sadioglu Zübeyde Nur Özkurt Çiğdem İlhan Abdullah Münci Yağcı

Published in: Balkan medical journal (2020)

In general, low serum levels of pre-transplant çell-free DNA seem to be associated with transplant-related morbidities and may be considered an adverse prognostic factor for allogeneic hematopoietic stem cell transplant recipients.

Keyphrases

hematopoietic stem cell
prognostic factors
bone marrow
stem cell transplantation
risk factors
single molecule
circulating tumor
cell free
low dose
drug induced
adverse drug